Entries tagged "Davis Polk "

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Davis Polk ."

11 result(s) displayed (13 - 23 of 23)

Davis Polk, Roche probe Genentech's DNA

Roche and Genentech have a long history. This time around, Davis Polk's John Butler and others take the lead for Roche. Continue reading

Posted on February 20, 2009 3:10 PM

Cravath helps Bristol feed a starved IPO market

Bristol-Myers plans to raise $500M-plus selling shares in Mead Johnson Nutrition Co. Cravath's Ronald Cami and Susan Webster are advising. Continue reading

Posted on February 6, 2009 1:15 PM

Don't bank on it

The Blackstone-Alliance dust up shows just how hard it is for private equity firms to buy into financial services, and the M&A bar gets ready for Tulane. Continue reading

Posted on January 23, 2009 12:48 PM

Davis Polk works point on Citi spinoff

Davis Polk attorneys have weighed in on Citi's restructuring. Continue reading

Posted on January 23, 2009 12:43 PM

They need a new drug

Expect Big Pharma to go shopping in biotechland, but with an eye for fire sales. Continue reading

Posted on January 9, 2009 2:10 PM

Citi directors call in Cravath

Citigroup's board has tapped Cravath's Robert Joffe for advice on the bank's many challenges. Continue reading

Posted on December 1, 2008 2:10 PM

Uncle Sam likes Simpson Thacher

Simpson Thacher attorneys are advising Treasury on its investments in U.S. banks. Continue reading

Posted on October 24, 2008 3:18 PM

Sovereign gets more than just capital

Sullivan & Cromwell's H. Rodgin Cohen and John Evangelakos advised Sovereign's special committee in its $1.9B sale to Santander. Continue reading

Posted on October 24, 2008 3:15 PM

Treasury taps Morgan Stanley to advise on AIG

Has Morgan Stanley become the go-to investment bank for the U.S. government? When the U.S. Department of Treasury hired a financial adviser -- the first... Continue reading

Posted on September 19, 2008 2:58 PM

Davis Polk, Goldman help Shionogi swallow Sciele

Davis Polk's Theodore Paradise weighs in on the Japanese group's $1.4B deal for Atlanta's Sciele. Continue reading

Posted on September 12, 2008 2:11 PM

Greenhill stays in the game with Roche, Applied Bio deals

Greenhill & Co.'s Robert Greenhill may have stepped down as CEO, but remains active in dealmaking as chairman. Continue reading

Posted on August 29, 2008 11:30 AM

Movable Type search results powered by Fast Search